Profile
Daniel Finley is the founder of Proteostasis Therapeutics, Inc. which was founded in 2006.
He received his undergraduate degree from Harvard University in 1980 and his doctorate degree from Massachusetts Institute of Technology in 1984.
Former positions of Daniel Finley
| Companies | Position | End |
|---|---|---|
| PROTEOSTASIS THERAPEUTICS, INC. | Founder | - |
Training of Daniel Finley
| Harvard University | Undergraduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Daniel Finley
